No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
AVDL240816C12500
- 3.93
- +0.13+3.42%
15min DelayClose Jul 22 16:00 ET
3.93High3.90Low
3.93Open3.80Pre Close4 Volume150 Open Interest12.50Strike Price1.57KTurnover118.57%IV-0.24%PremiumAug 16, 2024Expiry Date3.97Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8554Delta0.0448Gamma3.70Leverage Ratio-0.0248Theta0.0065Rho3.17Eff Leverage0.0097Vega
Intraday
- 5D
- Daily
News
Avadel Pharmaceuticals Plc's (NASDAQ:AVDL) Path To Profitability
Oppenheimer's Top SMID Ideas Within High-growth Themes
Avadel Pharmaceuticals to Join Russell 3000 Index
Oppenheimer Maintains Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Maintains Target Price $29
Rodman & Renshaw Initiates Avadel Pharmaceuticals(AVDL.US) With Buy Rating, Announces Target Price $27
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
Comments
The recent sale from a key insider at the current share price of US$14.12 raises concerns, despite insiders holding sizable shares in the company. This trend combined with limited recent insider buying causes a cautious outlook towards the company's stock.
$Avadel Pharmaceuticals(AVDL.US$
helloooooo dippy. should run rest of day. 👍🏻
Enjoy your Veterans day and have a blessed weekend.
helloooooo dippy. should run rest of day. 👍🏻
Enjoy your Veterans day and have a blessed weekend.
1
Insider sales surpassed insider buying at Avadel Pharmaceuticals in recent months, but yearly transactions are positive. Insider ownership aligns with shareholders, with recent sales not raising major concerns.
1
1
Read more